Nagraj Kashyap: Art, Not Science

<p style="font-weight:400;">In the healthtech industry, we tend to be very science-oriented. But my guest today, <a href='https://www.linkedin.com/in/nagrajkashyap/'>Nagraj Kayshap</a>, says the science of investing in healthtech companies is actually more of an art. it's contradictory. But if there’s anyone qualified to say so, it’s Nagraj. As managing partner at SoftBank, Nagraj decides what companies are best to form long-term investment relationships. So if you’re an entrepreneur looking for investors, this episode is really for you.</p> <p style="font-weight:400;">In this episode, we talk about what he looks for in a start-up, best pitching strategies, and the importance of community.</p> <p style="font-weight:400;">Do you have any thoughts? Please email us at <a href='mailto:hello@rosenmaninstitute.org'>hello@rosenmaninstitute.org</a>. We post new episodes every Monday. “<a href='https://rosenmaninstitute.org/podcast/'>The Health Technology Podcast</a>” is produced by <a href='https://www.linkedin.com/in/herminioneto/'>Herminio Neto</a>, hosted by <a href='https://www.linkedin.com/in/christine-winoto-8b412b/'>Christine Winoto</a>, and engineered by <a href='https://www.linkedin.com/in/aj-rojek/'>Andrew John Rojek</a></p> <p style="font-weight:400;"> </p>